Clown-Free Zone... sorry, no clowns allowed Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chuck_ponzi who wrote (84304)	3/22/2001 4:42:40 PM
From: Hobie1Kenobe	Read Replies (1) of 436258

IMNX - Immunex (IMNX) 18 15/16 +7/8: -- Update -- IMNX shares off 25% to 14 1/4 after hours. Immunex (IMNX) 18 15/16 +7/8: Immunex and American Home Products Corporation (AHP) announced that guidance from an independent data monitoring board indicates that ongoing studies of ENBREL (etanercept) in chronic heart failure (CHF) would not be able to meet efficacy endpoints. Based on this guidance, the companies have decided not to proceed with the large Phase 2/3 clinical studies in CHF; see press release.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next